Special Topics

UKAD has produced specific guidelines and resources for a number of common medical conditions requiring a TUE.

Athletes who are applying for a TUE for one of the medical conditions below must complete the relevant application form and fulfill all the requirements outlined in the relevant guidance documents.

Asthma

Athletes requiring a TUE for a prohibited substance to treat asthma (including acute exacerbations of asthma) should be familiar with the following documentation:

Guidelines on acute exacerbation of asthma

Beta-2 agonist TUE application form (for specific inhalers)

Standard TUE application form (for acute exacerbations of asthma)

ADHD

Athletes requiring a TUE for stimulant medication to treat attention deficit hyperactivity disorder (ADHD) should be familiar with the following documentation:

ADHD Policy

ADHD FAQs 

ADHD TUE application form

Diabetes

Athletes requiring a TUE for the use of insulins to treat diabetes should be familiar with the following documentation:

Diabetes Checklist 

Standard TUE application form

Hay Fever

Athletes who are wishing to use over the counter or prescribed medications to treat hay fever should be familiar with the following documentation:

Hay fever medications infographic

Hay fever guidelines

Please note: Athletes requiring a TUE for a prohibited substance (such as intramuscular triamcinolone injection or prednisolone tablets) used to treat hay fever must submit their applications in advance of treatment and provide medical evidence to justify their therapeutic need.

Emergency Medications

Athletes may, in the course of emergency treatment (e.g. surgery or an A&E admission), be provided with medication or methods of administration which are prohibited in sport. Please refer to the following resources to find out when a TUE is necessary in such circumstances.

Emergency medication infographic

EpiPen

Athletes who are prescribed an EpiPen, containing adrenaline, for use in emergency situations (such as an allergic reaction), should refer to the following guidelines:

EpiPen Guidelines